Viet Quoc Le

Viet Quoc Le

Auto-generated profile, based on publicly available information

Viet Quoc Le

Program in Cellular and Molecular Medicine, Children’s Hospital Boston, and Departments of Biological Chemistry and Molecular Pharmacology and of Medicine, Harvard Medical School, Boston, USA

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 March 2015 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
LMLi-Zhi Mi
Li-Zhi Mi
CBChristopher T. Brown
Christopher T. Brown
YGYijie Gao
Yijie Gao
YTYuan Tian
Yuan Tian
VLViet Q. Le
Viet Q. Le
TSTimothy A. Springer
Timothy A. Springer
Significance: Bone morphogenetic protein (BMP) activity is regulated by prodomains. Here, structures of BMP procomplexes reveal an open-armed conformation. In contrast, the evolutionarily related, latent TGF-β1 procomplex is cross-armed. We propose that in the TGF-β and BMP family, conversion between cross-armed and open-armed conformations may regulate release and activity of the growth factor.

13 September 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
ARAnindya Roy
Anindya Roy
LSLei Shi
Lei Shi
ACAshley Chang
Ashley Chang
XDXianchi Dong
Xianchi Dong
AFAndres Fernandez
Andres Fernandez
DBDavid Baker
David Baker
The RGD (Arg-Gly-Asp)-binding integrins αvβ6 and αvβ8 are clinically validated cancer and fibrosis targets of considerable therapeutic importance. Compounds that can discriminate between homologous αvβ6 and αvβ8 and other RGD integrins, stabilize specific conformational states, and have high thermal stability could have considerable therapeutic utility. Existing small molecule and antibody inhibitors do not have all these properties, and hence new approaches are needed. Here we describe a generalized method for computationally designing RGD-containing miniproteins selective for a single RGD integrin heterodimer and conformational state. We design hyperstable, selective αvβ6 and αvβ8 inhibitors that bind with picomolar affinity. CryoEM structures of the designed inhibitor-integrin complexes are very close to the computational design models, and show that the inhibitors stabilize specific conformational states of the αvβ6 and the αvβ8 integrins. In a lung fibrosis mouse model, the αvβ6 inhibitor potently reduced fibrotic burden and improved overall lung mechanics, demonstrating the therapeutic potential of de novo designed integrin binding proteins with high selectivity.

17 November 2006 in EMBO Reports
Verified
Journal Article
Open access
PDF file
JWJeanne M Wilson
Jeanne M Wilson
VLViet Q Le
Viet Q Le
CZCollin Zimmerman
Collin Zimmerman
RMRonen Marmorstein
Ronen Marmorstein
LPLorraine Pillus
Lorraine Pillus
Modulating transcription factors is crucial to executing sophisticated gene expression programs. The silent information regulator 2 (Sir2) family of NAD‐dependent protein deacetylases influences transcription by targeting proteins such as histones, p53 and forkhead‐box family transcription factors. Although apparently cytoplasmic, both mammalian SIRT2 and its yeast orthologue Hst2 have been implicated in transcriptional regulation. Here, we show that Hst2 moves between the nucleus and cytoplasm, but is largely cytoplasmic owing to efficient nuclear export. This nuclear exclusion is mediated by the exportin chromosomal region maintenance 1 (Crm1) and a putative leucine‐rich nuclear export sequence in Hst2, which overlaps a unique autoregulatory helix. Disruption of Hst2 export shows that nuclear exclusion inhibits the activity of Hst2 as a transcriptional repressor. Our identification of putative nuclear export sequences in numerous vertebrate SIRT2 proteins shows that active nuclear export can be a conserved mechanism for regulating Sir2 homologues.

31 October 2011 in Developmental Dynamics
Verified
Journal Article
Open access
PDF file
VLViet Q. Le
Viet Q. Le
KWKristi A Wharton
Kristi A Wharton
Background: Fibrodysplasia Ossificans Progressiva (FOP) is an autosomal dominant disorder characterized by episodic deposition of heterotopic bone in place of soft connective tissue. All FOP‐associated mutations map to the BMP type I receptor, ALK2, with the ALK2R206H mutant form found in the vast majority of patients. The mechanism(s) regulating the expressivity of hyperactive ALK2R206H signaling throughout a patient's life is not well understood. Results: In Drosophila, human ALK2R206H receptor induces hyperactive BMP signaling. As in vertebrates, elevated signaling associated with ALK2R206H in Drosophila is ligand‐independent. We found that a key determinant for ALK2R206H hyperactivity is a functional type II receptor. Furthermore, our results indicate that like its Drosophila ortholog, Saxophone (Sax), wild‐type ALK2 can antagonize, as well as promote, BMP signaling. Conclusions: The dual function of ALK2 is of particular interest given the heterozygous nature of FOP, as the normal interplay between such disparate behaviors could be shifted by the presence of ALK2R206H receptors. Our studies provide a compelling example for Drosophila as a model organism to study the molecular underpinnings of complex human syndromes such as FOP. Developmental Dynamics 241:200–214, 2012.

18 January 2018 in The EMBO Journal
Verified
Journal Article
Closed access
PDF file
VLViet Q Le
Viet Q Le
RIRoxana E Iacob
Roxana E Iacob
YTYuan Tian
Yuan Tian
WMWilliam McConaughy
William McConaughy
JJJustin Jackson
Justin Jackson
TSTimothy A Springer
Timothy A Springer

1 October 2009 in Genetics
Verified
Journal Article
Closed access
VTVern Twombly
Vern Twombly
EBErdem Bangi
Erdem Bangi
VLViet Le
Viet Le
BMBettina Malnic
Bettina Malnic
MSMatthew A Singer
Matthew A Singer
KWKristi A Wharton
Kristi A Wharton
In metazoans, bone morphogenetic proteins (BMPs) direct a myriad of developmental and adult homeostatic events through their heterotetrameric type I and type II receptor complexes. We examined 3 existing and 12 newly generated mutations in the Drosophila type I receptor gene, saxophone (sax), the ortholog of the human Activin Receptor-Like Kinase1 and -2 (ALK1/ACVRL1 and ALK2/ACVR1) genes. Our genetic analyses identified two distinct classes of sax alleles. The first class consists of homozygous viable gain-of-function (GOF) alleles that exhibit (1) synthetic lethality in combination with mutations in BMP pathway components, and (2) significant maternal effect lethality that can be rescued by an increased dosage of the BMP encoding gene, dpp+. In contrast, the second class consists of alleles that are recessive lethal and do not exhibit lethality in combination with mutations in other BMP pathway components. The alleles in this second class are clearly loss-of-function (LOF) with both complete and partial loss-of-function mutations represented. We find that one allele in the second class of recessive lethals exhibits dominant-negative behavior, albeit distinct from the GOF activity of the first class of viable alleles. On the basis of the fact that the first class of viable alleles can be reverted to lethality and on our ability to independently generate recessive lethal sax mutations, our analysis demonstrates that sax is an essential gene. Consistent with this conclusion, we find that a normal sax transcript is produced by saxP, a viable allele previously reported to be null, and that this allele can be reverted to lethality. Interestingly, we determine that two mutations in the first class of sax alleles show the same amino acid substitutions as mutations in the human receptors ALK1/ACVRl-1 and ACVR1/ALK2, responsible for cases of hereditary hemorrhagic telangiectasia type 2 (HHT2) and fibrodysplasia ossificans progressiva (FOP), respectively. Finally, the data presented here identify different functional requirements for the Sax receptor, support the proposal that Sax participates in a heteromeric receptor complex, and provide a mechanistic framework for future investigations into disease states that arise from defects in BMP/TGF-β signaling.